Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“Operates in Pharmaceuticals — Formulations & API.”
₹452 Cr revenue.
COGS 49.4%, employees 13.1%.
Historical valuation data not available.
Revenue segment breakdown not available.
| (₹ Cr) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹452 Cr +7.3% | ₹421 Cr +11.0% | ₹380 Cr -6.5% | ₹406 Cr +21.9% | ₹333 Cr +27.3% | ₹261 Cr +3.3% | ₹253 Cr |
| Other Income | ₹18 Cr +4.3% | ₹17 Cr +16.5% | ₹15 Cr -5.5% | ₹15 Cr +35.9% | ₹11 Cr +36.0% | ₹8 Cr +16.7% | ₹7 Cr |
| Total Income | ₹469 Cr +7.1% | ₹438 Cr +11.2% | ₹394 Cr -6.4% | ₹421 Cr +22.4% | ₹344 Cr +27.6% | ₹270 Cr +3.6% | ₹260 Cr |
| COGS | ₹223 Cr +5.4% | ₹212 Cr +16.4% | ₹182 Cr +0.8% | ₹180 Cr +28.7% | ₹140 Cr +19.7% | ₹117 Cr -1.5% | ₹119 Cr |
| ₹400 Cr +6.4% | ₹376 Cr +10.5% | ₹341 Cr +3.0% | ₹331 Cr +26.1% | ₹262 Cr +11.4% | ₹235 Cr +4.5% | ₹225 Cr | |
| Profit Before Tax | ₹69 Cr +11.6% | ₹62 Cr +15.5% | ₹54 Cr -40.8% | ₹91 Cr +10.6% | ₹82 Cr +137.7% | ₹34 Cr -2.0% | ₹35 Cr |
| ₹18 Cr +7.8% | ₹17 Cr +22.9% | ₹14 Cr -40.9% | ₹23 Cr +12.9% | ₹21 Cr +121.1% | ₹9 Cr -7.9% | ₹10 Cr | |
| Net Profit | ₹51 Cr +13.0% | ₹45 Cr +12.9% | ₹40 Cr -40.7% | ₹67 Cr +9.8% | ₹61 Cr +143.9% | ₹25 Cr +2.3% | ₹25 Cr |
| Other Comprehensive Income | (₹0.79 Cr) ↓ Decline | ₹0.15 Cr ↑ Recovery | (₹1 Cr) -91.0% | (₹0.64 Cr) | (₹0.03 Cr) +90.5% | (₹0.29 Cr) +48.1% | (₹0.57 Cr) |
| EPS | ₹17.58 | ₹15.56 | ₹13.63 | ₹22.99 | ₹20.93 | ₹8.58 | ₹8.39 |
| Diluted Shares | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
No earnings call transcripts available.
Amrutanjan Health Care Limited has informed the Exchange regarding 'Financial Results-Machine Readable Format'.
Amrutanjan Health Care Limited has informed the Exchange about Investor Presentation
Amrutanjan Health Care Limited has informed the Exchange that Board of Directors at its meeting held on May 08, 2026, recommended Final Dividend of Rs. 2.90 per equity share.
Amrutanjan Health Care Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Amrutanjan Health Care Limited has informed the Exchange about Product launch
Amrutanjan Health Care Limited has informed the Exchange regarding 'Rephrasing of ESOP'.
Amrutanjan Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Amrutanjan Health Care Limited has informed the Exchange about Action(s) initiated or orders passed
Amrutanjan Health Care Limited has informed the Exchange about General Updates
The Exchange has sought clarification from Amrutanjan Health Care Limited with respect to recent news item captioned Amrutanjan held Mylapore Kapaleeswarar Temple land till 2018; Rs 9.74 crore dues: H...
Amrutanjan Health Care Limited has informed the Exchange about Investor Presentation
Amrutanjan Health Care Limited has informed the Exchange that Record date for the purpose of Dividend is 07-Feb-2026.
Amrutanjan Health Care Limited has informed the Exchange that Board of Directors at its meeting held on February 03, 2026, declared Interim Dividend of Re. 1 per equity share.
Amrutanjan Health Care Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
Amrutanjan Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.